Suppr超能文献

抗凝治疗的脑静脉血栓形成患者的早期再通。

Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation.

机构信息

From the Department of Neurosciences and Mental Health (Neurology), Hospital Santa Maria/CHULN, University of Lisbon, Portugal (D.A.d.S., M.C.D., P.C., J.M.F.).

Institute of Anatomy, Faculdade de Medicina, University of Lisbon (D.A.d.S., L.L.N., S.P.).

出版信息

Stroke. 2020 Apr;51(4):1174-1181. doi: 10.1161/STROKEAHA.119.028532. Epub 2020 Mar 2.

Abstract

Background and Purpose- The hypothesis that venous recanalization prevents progression of venous infarction is not established in patients with cerebral venous thrombosis (CVT). Evidence is also scarce on the association between residual symptoms, particularly headache, and the recanalization grade. We aimed to assess, in patients with CVT treated with standard anticoagulation, (1) the rate of early venous recanalization, (2) whether lack of early recanalization was predictor of parenchymal brain lesion progression, and (3) the prevalence and features of persistent headache according to the recanalization grade achieved. Methods- PRIORITy-CVT (Pathophysiology of Venous Infarction - Prediction of Infarction and Recanalization in CVT) was a multicenter, prospective, cohort study including patients with newly diagnosed CVT. Standardized magnetic resonance imaging was performed at inclusion (≤24 hours of therapeutic anticoagulation), days 8 and 90. Potential imaging predictors of recanalization were predefined and analyzed at each anatomical segment. Primary outcomes were rate of early recanalization and brain lesion progression at day 8. Secondary outcomes were headache (days 8 and 90) and functional outcome (modified Rankin Scale at days 8 and 90). Results- Sixty eight patients with CVT were included, of whom 30 (44%) had parenchymal lesions. At the early follow-up (n=63; 8±2 days), 68% (n=43) of patients had partial recanalization and 6% (n=4) full recanalization. Early recanalization was associated both with early regression (=0.03) and lower risk of enlargement of nonhemorrhagic lesions (=0.02). Lesions showing diffusion restriction (n=12) were fully reversible in 66% of cases, particularly in patients showing early venous recanalization. Evidence of new or enlarged hemorrhagic lesions, headache at days 8 and 90, and unfavorable functional outcome at days 8 and 90 were not significantly different in patients achieving recanalization. Conclusions- Venous recanalization started within the first 8 days of therapeutic anticoagulation in most patients with CVT and was associated with early regression of nonhemorrhagic lesions, including venous infarction. There was an association between persistent venous occlusion at day 8 and enlargement of nonhemorrhagic lesions.

摘要

背景与目的- 静脉再通可预防脑静脉血栓形成(CVT)患者静脉梗死进展的假说尚未得到证实。关于残留症状(尤其是头痛)与再通程度之间的关系,证据也很少。我们旨在评估接受标准抗凝治疗的 CVT 患者中:(1)早期静脉再通率;(2)早期无再通是否是实质脑损伤进展的预测因素;(3)根据达到的再通程度,持续性头痛的发生率和特征。方法- PRIORITy-CVT(静脉梗死的病理生理学-预测 CVT 中的梗死和再通)是一项多中心前瞻性队列研究,纳入了新诊断为 CVT 的患者。在纳入时(治疗性抗凝治疗后≤24 小时)、第 8 天和第 90 天进行标准化磁共振成像。在每个解剖段预先定义并分析潜在的影像学再通预测因子。主要结局是第 8 天的早期再通率和脑损伤进展。次要结局是头痛(第 8 天和第 90 天)和功能结局(第 8 天和第 90 天的改良 Rankin 量表)。结果- 共纳入 68 例 CVT 患者,其中 30 例(44%)有实质病变。在早期随访时(n=63;8±2 天),68%(n=43)的患者部分再通,6%(n=4)的患者完全再通。早期再通与早期消退(=0.03)和非出血性病变扩大的风险降低(=0.02)均相关。12 例弥散受限的病变中有 66%(n=8)完全可逆,尤其是在早期静脉再通的患者中。达到再通的患者中,新发或扩大的出血性病变、第 8 天和第 90 天的头痛以及第 8 天和第 90 天的不良功能结局并无显著差异。结论- 在大多数 CVT 患者中,静脉再通在治疗性抗凝治疗的前 8 天内开始,并与非出血性病变(包括静脉梗死)的早期消退相关。第 8 天静脉持续闭塞与非出血性病变的扩大有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验